Minocycline for patients with ALS.
Carrì
Maria Teresa
MT
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy*; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004195:Disease Models, Animal; D004359:Drug Therapy, Combination; D006801:Humans; D051379:Mice; D018345:Mice, Knockout; D008911:Minocycline / Q000009:adverse effects / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D013482:Superoxide Dismutase / Q000235:genetics; D000072105:Superoxide Dismutase-1; D017211:Treatment Failure
D000900:Anti-Bacterial Agents; C000606290:SOD1 protein, human; C000606291:Sod1 protein, mouse; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1; D008911:Minocycline